General Information |
|
| NSE Symbol* | BLISSGVS |
| Name of the Company* | BLISS GVS PHARMA LIMITED |
| ISIN* | INE416D01022 |
| Type of Meeting |
1) Board Meeting |
| Details of Committee Meeting or Other Type of Meeting | |
| Type of Intimation* | New |
| Reason for Re-schedule (postpone or prepone) / Cancellation | |
| Proposed Meeting Date | 2025-07-29 |
| Original Meeting Date | |
| Whether trading window is closed* | Yes |
| Trading Window Closure- Start date | 2025-07-01 |
| Details of Trading Window Closure End date | 2025-07-31 |
| Short Notice | |
| Date of Report* | 2025-07-22 |
Agenda Details |
|
| Agenda* |
1) Financial results |
| Whether results are audited or unaudited | Unaudited |
| Nature of report standalone or consolidated | Standalone And Consolidated |
| Period end Type | Quarterly |
| Period up to (Month) | June |
| Period up to (Year) | 2025 |
| Mode of raising Funds | |
| Type of Dividend | |
| Remarks (website dissemination) | Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, July 29, 2025 at the registered office of the Company to consider and approve, inter alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2025. |